Arcadia Biosciences, Inc. - Common Stock (RKDA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q1 2023

Type / Class
Equity / Common Stock
Symbol
RKDA on Nasdaq
Shares outstanding
1,390,020
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcadia Biosciences, Inc. - Common Stock (RKDA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 4.9% $17,028 68,111 SABBY MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$639,508 0
2022 Q4 2,366,535 $639,500 -$254,578 $0.27 26
2022 Q3 3,250,077 $1,714,000 +$789,571 $0.53 20
2022 Q2 1,662,059 $1,663,000 -$232,356 $1.00 17
2022 Q1 1,889,399 $2,643,000 -$455,447 $1.40 22
2021 Q4 2,277,691 $2,365,000 -$2,447,713 $1.04 23
2021 Q3 3,161,711 $6,544,000 +$1,276,646 $2.07 18
2021 Q2 2,492,390 $7,401,000 +$4,102,330 $2.97 24
2021 Q1 1,150,714 $3,170,000 +$191,543 $2.75 22
2020 Q4 1,116,093 $2,823,000 +$624,941 $2.53 18
2020 Q3 869,117 $2,435,000 +$932,808 $2.80 18
2020 Q2 523,085 $1,969,000 +$371,529 $3.77 14
2020 Q1 427,045 $1,217,000 -$643,195 $2.86 10
2019 Q4 496,981 $2,722,000 -$790,865 $5.48 13
2019 Q3 662,670 $3,101,000 +$1,149,076 $4.68 17
2019 Q2 479,719 $1,471,000 +$709,696 $3.07 13
2019 Q1 192,404 $1,348,000 +$38,017 $7.00 9
2018 Q4 281,426 $892,000 -$736,401 $3.17 8
2018 Q3 438,889 $2,144,000 -$22,391 $4.88 12
2018 Q2 342,140 $2,822,000 -$4,604,725 $8.25 11
2018 Q1 395,405 $10,022,000 +$10,014,997 $24.01 10
2017 Q4 26,228 $7,000 +$7,000 $0.27 1